Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Adaptive Biotechnologies Corp shares valued at $148,200 were sold by ROBINS HARLAN S on Nov 10 ’25. At $14.82 per share, ROBINS HARLAN S sold 10,000 shares. The insider’s holdings dropped to 1,269,524 shares worth approximately $18.41 million following the completion of this transaction.
Also, ROBINS CHAD M sold 86,161 shares, netting a total of over 1,269,152 in proceeds. Following the sale of shares at $14.73 each, the insider now holds 2,873,088 shares.
Before that, ROBINS CHAD M had sold 1,867 shares from its account. In a trade valued at $28,005, the CEO and Chairman traded Adaptive Biotechnologies Corp shares for $15.00 each. Upon closing the transaction, the insider’s holdings decreased to 1,867 shares, worth approximately $41.61 million.
As published in their initiating research note from Guggenheim on September 30, 2025, Adaptive Biotechnologies Corp [ADPT] has been a Buy and the price target has been revised to $20. Analysts at Craig Hallum started covering the stock with ‘”a Buy”‘ outlook in a report released in mid June. As of March 21, 2025, Goldman has increased its “Neutral” rating to a “Buy” for ADPT.
Analyzing ADPT Stock Performance
On last trading session, Adaptive Biotechnologies Corp [NASDAQ: ADPT] plunged -0.21% to $14.5. The stock’s lowest price that day was $14.36, but it reached a high of $15.05 in the same session. During the last five days, there has been a drop of approximately -17.57%. Over the course of the year, Adaptive Biotechnologies Corp shares have jumped approximately 149.14%. Shares of the company reached a 52-week high of $17.89 on 10/21/25 and a 52-week low of $5.96 on 01/02/25.
Support And Resistance Levels for Adaptive Biotechnologies Corp (ADPT)
According to the 24-hour chart, there is a support level at 14.22, which, if violated, would cause prices to drop to 13.95. In the upper region, resistance lies at 14.91. The next price resistance is at 15.33. RSI (Relative Strength Index) is 39.60 on the 14-day chart, showing neutral technical sentiment.
Is Adaptive Biotechnologies Corp subject to short interest?
Stocks of Adaptive Biotechnologies Corp saw a sharp steep in short interest on 2025-10-31 dropping by -0.58 million shares to 9.01 million. Data from Yahoo Finance shows that the short interest on 2025-09-30 was 9.59 million shares. A decline of -6.42% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 4.94 of the overall float, the days-to-cover ratio (short ratio) decline to 4.94.
Which companies own the most shares of Adaptive Biotechnologies Corp (ADPT)?
In terms of Adaptive Biotechnologies Corp share price expectations, FactSet research, analysts set an average price target of 20 in the next 12 months, up nearly 37.65% from the previous closing price of $14.53. Analysts anticipate Adaptive Biotechnologies Corp stock to reach 20 by 2025, with the lowest price target being 20. In spite of this, 11 analysts ranked Adaptive Biotechnologies Corp stock as Hold at the end of 2025. On January 05, 2023, Scotiabank assigned a price target of “a Sector outperform” to the stock and initiated coverage with a $15.
